应用EWGSOP2替代EWGSOP1对老年住院患者肌少症检出影响的后果
该研究基于SAGE研究144例老年住院患者数据,比较EWGSOP2与EWGSOP1算法识别肌少症的一致性。EWGSOP1检出率为27.7%,显著高于EWGSOP2的18.1%(p<0.05);男性检出率从37.9%降至19.4%(p<0.05%),女性变化不显著。两种算法总体分类一致率为81.25%,但EWGSOP1检出的41例中仅20例(48.8%)被EWGSOP2确诊。
要点
- EWGSOP2检出肌少症总体患病率显著低于EWGSOP1(18.1% vs 27.7%,p<0.05)。
- 男性检出率在EWGSOP2下显著降低(37.9% vs 19.4%,p<0.05%),女性变化不显著。
- 两算法总体分类一致率81.25%,但个体病例重叠低,EWGSOP1检出者中仅48.8%被EWGSOP2确诊。
核心结论
- EWGSOP1与EWGSOP2在老年住院患者肌少症检出中存在显著不匹配,EWGSOP2总体患病率及男性检出数显著更低,女性绝对数相对稳定但个体病例重叠低。
研究设计与样本
- 基于已发表的SAGE研究数据集,纳入144例老年住院患者(86女,58男,平均年龄80.7±5.6岁),测量步速、握力和DXA四肢肌肉量,分析两种算法识别肌少症的一致性。
主要发现
- EWGSOP1检出肌少症41例(27.7%),显著高于EWGSOP2的26例(18.1%)(p<0.05)。
- 女性检出率EWGSOP1为22.1%、EWGSOP2为17.4%(差异不显著);男性分别为37.9%与19.4%(p<0.05%)。
- 总体分类一致率81.25%(女性81.4%,男性81.0%)。
- EWGSOP1检出的41例中,仅20例(48.8%)被EWGSOP2确诊(女性9/19,47.4%;男性11/22,50.0%)。
临床怎么用
- 临床采用EWGSOP2筛查肌少症时,应意识到其较EWGSOP1显著降低男性检出率,可能漏诊部分既往定义下的肌少症患者。
- 两种算法个体病例重叠低,更换诊断标准时需重新评估患者肌少症状态,避免仅依据旧标准分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: we examined the consequences of applying the new EWGSOP2 algorithm for sarcopenia screening instead of the former EWGSOP algorithm (EWGSOP1) in geriatric inpatients. METHODS: the dataset of our formerly published Sarcopenia in Geriatric Elderly (SAGE) study includes 144 geriatric inpatients (86 women, 58 men, mean age 80.7±5.6 years) with measurements of gait speed, handgrip strength and appendicular muscle mass by dual x-ray absorptiometry (DXA). We analysed the agreement between EWGSOP and EWGSOP2 algorithms in identifying patients as sarcopenic/non-sarcopenic. Differences in the distribution sarcopenic vs. non-sarcopenic were assessed by Chi²-test. RESULTS: sarcopenia prevalence according to EWGSOP1 (41 (27.7%)) was significantly higher than with EWGSOP2 (26(18.1%), p<0.05). The sex-specific sarcopenia prevalence was 22.1% (EWGSOP1) and 17.4% (EWGSOP2), respectively, for women (difference not significant) and 37.9% vs. 19.4% for men (p<0.05%). The overall agreement in classifying subjects as sarcopenic/non-sarcopenic was 81.25% (81.4% for women, 81.0% for men). However, among the 41 sarcopenia cases identified by EWGSOP1, only 20 (48.8%) were diagnosed with sarcopenia by EWGSOP2 (9/19 w (47.4%), 11/22 m (50.0%)). Ten of 19 women (52.6%) and 11 of 22 men (50.0%) diagnosed with sarcopenia by EWGSOP1 were missed by EWGSOP2, while 6 of 15 women (40.0%) and 0 of 11 men (0.0%) were newly diagnosed. DISCUSSION: there is a substantial mismatch in sarcopenia case finding according to EWGSOP1 and EWGSOP2. The overall prevalence and the number of men diagnosed with sarcopenia are significantly lower in EWGSOP2. While the absolute number of women identified as sarcopenic remains relatively constant, the overlap of individual cases between the two definitions is low.
引用
- Reiss J, Iglseder B, Alzner R, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing. 2019. PMID: 31112221. doi:10.1093/ageing/afz035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。